Midazolam Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Midazolam Hydrochloride Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on 04/02/2020. Reported reason: Demand increase for the drug
Shortage Details
- Status
- Current
- Company
- Fresenius Kabi USA, LLC
- Package NDC
- 76045-211-20
- Dosage Form
- Injection
- Presentation
- Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2 mL (NDC 76045-211-20)
- Initial Posting
- 04/02/2020
- Revised Date
Reason
Demand increase for the drug